The goal of this project is to apply biomarkers of exposures and outcomes that have been developed thus far in the UC Davis Superfund laboratories to human populations with likely exposures to hazardous substances so as to provide laboratory/biologic assessment of exposures and health outcomes. This project is timely at this stage of the UC Davis Superfund effort in taking assay techniques that have been developed here into a real-lifer human setting to provide both practical information about the feasibility of such approaches as well as objective data about the likelihood of exposure of human populations to toxicants of interest to Superfund and the relation of such exposures ti adverse health effects in humans. Specifically the aims of this project are: a) evaluate the adverse human health effects, particularly neurologic and neurobehavioral effects, or organophosphate (OP) exposure in children in a farmworker community using monthly urine samples from mothers (including farmworkers and non-farmworkers) and their children to assess (OP) metabolites, such as glucuronides of Ops; b) to determine the prevalence of exposure and compare immunoassay to gas chromatography results; c) to evaluate the likely routes of exposure; d) to evaluate the relation of potential exposure to environmental endocrine disruptors and other potentially hazardous exposures to adverse reproductive and other human health effects in a residential community adjacent to a local Superfund site; and e) to compare thyroid hormone levels in opportunistic blood samples and treatment for thyroid disorders of household members who are likely and those who are unlikely to be exposed. This project will also provide epidemiologic field studies to examine the role of exposure to hazardous environmental substances in increasing the risk of adverse human health effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
2P42ES004699-14
Application #
6333686
Study Section
Special Emphasis Panel (ZES1-MAO-A (G2))
Project Start
1987-09-30
Project End
2005-03-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2000
Total Cost
$165,230
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Harris, Todd R; Kodani, Sean; Rand, Amy A et al. (2018) Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury. Mol Pharmacol 94:834-841
Bever, Candace S; Rand, Amy A; Nording, Malin et al. (2018) Effects of triclosan in breast milk on the infant fecal microbiome. Chemosphere 203:467-473
Zheng, Jing; McKinnie, Shaun M K; El Gamal, Abrahim et al. (2018) Organohalogens Naturally Biosynthesized in Marine Environments and Produced as Disinfection Byproducts Alter Sarco/Endoplasmic Reticulum Ca2+ Dynamics. Environ Sci Technol 52:5469-5478
Lakkappa, Navya; Krishnamurthy, Praveen T; Yamjala, Karthik et al. (2018) Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development. J Pharm Biomed Anal 149:457-464
Guedes, A G P; Aristizabal, F; Sole, A et al. (2018) Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis. J Vet Pharmacol Ther 41:230-238
Heikenfeld, J; Jajack, A; Rogers, J et al. (2018) Wearable sensors: modalities, challenges, and prospects. Lab Chip 18:217-248
Minaz, Nathani; Razdan, Rema; Hammock, Bruce D et al. (2018) An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins Other Lipid Mediat 136:84-89
Lassabe, Gabriel; Kramer, Karl; Hammock, Bruce D et al. (2018) Noncompetitive Homogeneous Detection of Small Molecules Using Synthetic Nanopeptamer-Based Luminescent Oxygen Channeling. Anal Chem 90:6187-6192
?ertíková Chábová, V?ra; Kujal, Petr; Škaroupková, Petra et al. (2018) Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney Blood Press Res 43:329-349
Kodani, Sean D; Bhakta, Saavan; Hwang, Sung Hee et al. (2018) Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase. Bioorg Med Chem Lett 28:762-768

Showing the most recent 10 out of 1149 publications